The serine phosphorylation hypothesis of polycystic ovary syndrome: a unifying mechanism for hyperandrogenemia and insulin resistance  Andrew A. Bremer,

Slides:



Advertisements
Similar presentations
STEROIDOGENESIS NABIL BASHIR 2009.
Advertisements

Steroidogenesis. Steroid hormones Cholesterol derivative –Dietary source Carried in blood as a part of lipoproteins –Synthesized by liver –Receptor-mediated.
Biosynthesis of steroid hormones Synthesis and hydroxylation of calciols Biochemistry II Lecture (J.S.)
Human Endocrine Physiology February 27, 2014.
Steroid Hormones.
GLOMERULOSA CAPSULE FASCICULATA ALDOSTERONE ADRENAL CORTEX MEDULLA
Steroid Hormones.
Reproductive Module Dr.Halima Babiker. Overview of Steroid Hormones  Steroid hormones: produced in the adrenal cortex, testis, ovary, and some peripheral.
Steroidgenesis and Congenital Adrenal Hyperplasia
This diagram illustrates adrenal, ovarian, and testicular steroidogenic pathways. Under the usual circumstances in humans, 17-OHP is a poor substrate for.
Premature Adrenarche - A Common Condition with Variable Presentation
Nat. Rev. Urol. doi: /nrurol
Human Steroid Biosynthesis
Selective impairment in glycogen synthase kinase-3 and mitogen-activated protein kinase phosphorylation: comparisons with the hyperandrogenic and the.
Endocrine and cardiometabolic cord blood characteristics of offspring born to mothers with and without polycystic ovary syndrome  Nadine M.P. Daan, M.D.,
The effect of cinnamon extract on insulin resistance parameters in polycystic ovary syndrome: a pilot study  Jeff G. Wang, M.D., Richard A. Anderson,
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report  Ricardo Azziz, M.D., M.P.H., Enrico Carmina,
Male contraception Fertility and Sterility
Anabolic steroid–induced hypogonadism: diagnosis and treatment
The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition  Lorraine Dennerstein,
Comparison of hormonal and metabolic markers after a high-fat, Western meal versus a low-fat, high-fiber meal in women with polycystic ovary syndrome 
Kalliopi Kotsa, M. D. , Ph. D. , Maria P. Yavropoulou, M. D
Michael M. Alper, M.D.  Fertility and Sterility 
Michal Youngster, M. D. , Valerie L. Ward, M. D. , M. P. H. , Emily A
Raoul Orvieto, M. D. , M. Sc. , Eduard Hod, M. D
Possible metformin effect on adrenal androgens during pretreatment and IVF cycle in women with polycystic ovary syndrome  Sigrun B. Kjøtrød, M.D., Arne.
Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3) in IVF patients with polycystic ovary syndrome: correlations with outcome 
Aromatase, microRNA, and inflammation: a complex relationship
Insulin resistance in oligomenorrheic infertile women with non-polycystic ovary syndrome  Shirei Ohgi, M.D., Koji Nakagawa, M.D., Ph.D., Rieko Kojima,
Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study  Angela Kerchner, B.A., Whitney Lester,
Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels 
Shahin Ghadir, M.D., Ricardo Azziz, M.D., M.P.H., M.B.A. 
Regulation of catechol O-methyltransferase expression in granulosa cells: a potential role for follicular arrest in polycystic ovary syndrome  Sana M.
Live birth of twins derived from zona-free oocytes
Expression of growth differentiation factor-9 and bone morphogenetic protein-15 in oocytes and cumulus granulosa cells of patients with polycystic ovary.
Rebecca A. Feldman, M. D. , Kathleen O'Neill, M. D. , Samantha F
Evolutionary determinants of polycystic ovary syndrome: part 1
Letrozole versus combined metformin and clomiphene citrate for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a randomized.
Clinical course of depression symptoms and predictors of enduring depression risk in women with polycystic ovary syndrome: Results of a longitudinal study 
Ontogeny of the ovary in polycystic ovary syndrome
Serum soluble leptin receptor levels and free leptin index in women with polycystic ovary syndrome: relationship to insulin resistance and androgens 
Robert F. Casper, M.D.  Fertility and Sterility 
Bisphenol A and ovarian steroidogenesis
Influence of acupuncture stimulation on pregnancy rates for women undergoing embryo transfer  Caroline Smith, Ph.D., Meaghan Coyle, B.Hlth.Sc. (Acup.),
Effect of rejuvenation hormones on spermatogenesis
Katherine D. LaGuardia, M. D. , M. P. H. , Alan C. Fisher, Dr. P. H
Cyclooxygenase-2 in the kidney: good, BAD, or both?
Andrew C. Bjonnes, M.S., Richa Saxena, Ph.D., Corrine K. Welt, M.D. 
Mevastatin inhibits proliferation of rat ovarian theca–interstitial cells by blocking the mitogen-activated protein kinase pathway  Jakub Kwintkiewicz,
Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity  Jean-Patrice Baillargeon, M.D.,
Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D. 
CDB-2914, a novel selective progesterone receptor modulator, differentially regulates endometrial gene expression in the proliferative phase of the menstrual.
Ri-Cheng Chian, Ph.D., Peter S. Uzelac, M.D., Geeta Nargund, M.D. 
Simvastatin improves biochemical parameters in women with polycystic ovary syndrome: results of a prospective, randomized trial  Antoni J. Duleba, M.D.,
Effects of treatment with testosterone alone or in combination with estrogen on insulin sensitivity in postmenopausal women  Hong Zang, M.D., Kjell Carlström,
Erkut Attar, M.D., Serdar E. Bulun, M.D.  Fertility and Sterility 
Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin  Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.
Paolo Moghetti, M.D.  Fertility and Sterility 
Insulin growth factors may be implicated in human sperm capacitation
Insulin resistance, obesity, inflammation, and depression in polycystic ovary syndrome: biobehavioral mechanisms and interventions  Kristen Farrell, M.S.,
Ronald M. Yang, M. D. , Richard A. Fefferman, M. D. , Charles E
A new era in ovulation induction
In vitro sildenafil citrate use as a sperm motility stimulant
Androgen responses to adrenocorticotropic hormone infusion among individual women with polycystic ovary syndrome  Kevin H. Maas, M.D., Ph.D., Sandy Chuan,
Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels 
The pathways of androgen biosynthesis.
Diabetes mellitus and insulin resistance in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis 
Adipocytes from women with polycystic ovary syndrome demonstrate altered phosphorylation and activity of glycogen synthase kinase 3  Wendy Chang, M.D.,
Is there a role for diet in ameliorating the reproductive sequelae associated with chronic low-grade inflammation in polycystic ovary syndrome and obesity? 
Marita Pall, M. D. , Ph. D. , Margaret Nguyen, B. S
Presentation transcript:

The serine phosphorylation hypothesis of polycystic ovary syndrome: a unifying mechanism for hyperandrogenemia and insulin resistance  Andrew A. Bremer, M.D., Ph.D., Walter L. Miller, M.D.  Fertility and Sterility  Volume 89, Issue 5, Pages 1039-1048 (May 2008) DOI: 10.1016/j.fertnstert.2008.02.091 Copyright © 2008 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Integrated view of human steroidogenesis, showing adrenal and gonadal pathways. Reaction 1: P450scc converts cholesterol to pregnenolone. Reaction 2: 3β-HSD converts Δ5 steroids (pregnenolone, 17OH-pregnenolone, DHEA, androstenediol) to the corresponding Δ4 steroids (progesterone, 17OH-progesterone, androstenedione, testosterone). Reaction 3: P450c17 catalyzes the 17α-hydroxylation of pregnenolone and progesterone. Reaction 4: The 17,20-lyase activity of P450c17 converts 17OH-pregnenolone to DHEA; the conversion of 17OH-progesterone to androstenedione occurs in cattle and rodents, but human P450c17 cannot catalyze this reaction efficiently. Reaction 5: P450c21 catalyzes the 21-hydroxylation of progesterone and 17OH-progesterone. Reaction 6: Deoxycorticosterone (DOC) can be converted to corticosterone by either P450c11AS (in the adrenal zona glomerulosa) or P450c11β (in the adrenal zona fasciculata). Reaction 7: P450c11β converts 11-deoxycortisol to cortisol. Reactions 8 and 9: P450c11AS catalyzes 18 hydroxylase (reaction 8) and 18 methyl oxidase activities (reaction 9) to produce aldosterone in the adrenal zona glomerulosa. Reaction 10: Two isozymes of 17βHSD activate sex steroids: 17β-HSD1 produces estradiol and 17β-HSD3 produces androgens. In peripheral tissues 17β-HSD5 has similar activity to 17β-HSD3, and 17β-HSD2 and -4 catalyze the “reverse” reactions to inactivate sex steroids. Reaction 11: P450aro aromatizes C19 androgenic steroids to C18 estrogens. Fertility and Sterility 2008 89, 1039-1048DOI: (10.1016/j.fertnstert.2008.02.091) Copyright © 2008 American Society for Reproductive Medicine Terms and Conditions

Figure 2 The differential effects of tyrosine (Tyr) vs. serine (Ser) phosphorylation of the IR. Tyrosine phosphorylation of IRβ after the binding of insulin to IRα leads to tyrosine phosphorylation of IRS-1 and the activation of downstream effector molecules. However, serine phosphorylation of IRβ inhibits IRS-1 activation. Fertility and Sterility 2008 89, 1039-1048DOI: (10.1016/j.fertnstert.2008.02.091) Copyright © 2008 American Society for Reproductive Medicine Terms and Conditions

Figure 3 The serine phosphorylation hypothesis. The serine phosphorylation hypothesis proposes that a dominantly inherited kinase (or kinases) serine phosphorylates both IRβ and P450c17, leading to insulin resistance and increased androgen production, respectively. Both positive and negative regulatory factors may modulate kinase activity. Fertility and Sterility 2008 89, 1039-1048DOI: (10.1016/j.fertnstert.2008.02.091) Copyright © 2008 American Society for Reproductive Medicine Terms and Conditions

Figure 4 Regulation of 17,20-lyase activity by reversible phosphorylation of P450c17. Arrows indicate stimulation, and blocked lines indicate inhibition. A cyclic adenosine monophosphate (cAMP)–dependent serine/threonine (S/T) kinase stimulates the 17,20-lyase activity of P450c17 and a tyrosine (Y) kinase, SET and okadaic acid (OA) inhibit protein phosphatase 2A (PP2A). The nature of the kinases that regulate SET and that presumably regulate S/T kinases are unknown. ATP = adenosine triphosphate; ADP = adenosine diphosphate; OR = P450 oxidoreductase; b5 = cytochrome b5. [Derived from A.V. Pandey et al. J Biol Chem 2003;278:2837–44. (131)] Fertility and Sterility 2008 89, 1039-1048DOI: (10.1016/j.fertnstert.2008.02.091) Copyright © 2008 American Society for Reproductive Medicine Terms and Conditions